These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

529 related items for PubMed ID: 14610251

  • 1. Hypothalamic neuronal histamine in genetically obese animals: its implication of leptin action in the brain.
    Itateyama E, Chiba S, Sakata T, Yoshimatsu H.
    Exp Biol Med (Maywood); 2003 Nov; 228(10):1132-7. PubMed ID: 14610251
    [Abstract] [Full Text] [Related]

  • 2. Hypothalamic neuronal histamine as a target of leptin in feeding behavior.
    Yoshimatsu H, Itateyama E, Kondou S, Tajima D, Himeno K, Hidaka S, Kurokawa M, Sakata T.
    Diabetes; 1999 Dec; 48(12):2286-91. PubMed ID: 10580415
    [Abstract] [Full Text] [Related]

  • 3. Glucagon-like peptide-1, corticotropin-releasing hormone, and hypothalamic neuronal histamine interact in the leptin-signaling pathway to regulate feeding behavior.
    Gotoh K, Fukagawa K, Fukagawa T, Noguchi H, Kakuma T, Sakata T, Yoshimatsu H.
    FASEB J; 2005 Jul; 19(9):1131-3. PubMed ID: 15894564
    [Abstract] [Full Text] [Related]

  • 4. Specificity of leptin action on elevated blood glucose levels and hypothalamic neuropeptide Y gene expression in ob/ob mice.
    Schwartz MW, Baskin DG, Bukowski TR, Kuijper JL, Foster D, Lasser G, Prunkard DE, Porte D, Woods SC, Seeley RJ, Weigle DS.
    Diabetes; 1996 Apr; 45(4):531-5. PubMed ID: 8603777
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Leptin increases hypothalamic pro-opiomelanocortin mRNA expression in the rostral arcuate nucleus.
    Schwartz MW, Seeley RJ, Woods SC, Weigle DS, Campfield LA, Burn P, Baskin DG.
    Diabetes; 1997 Dec; 46(12):2119-23. PubMed ID: 9392508
    [Abstract] [Full Text] [Related]

  • 7. Hypothalamic pro-opiomelanocortin mRNA is reduced by fasting and [corrected] in ob/ob and db/db mice, but is stimulated by leptin.
    Mizuno TM, Kleopoulos SP, Bergen HT, Roberts JL, Priest CA, Mobbs CV.
    Diabetes; 1998 Feb; 47(2):294-7. PubMed ID: 9519731
    [Abstract] [Full Text] [Related]

  • 8. Apelin and the proopiomelanocortin system: a new regulatory pathway of hypothalamic α-MSH release.
    Reaux-Le Goazigo A, Bodineau L, De Mota N, Jeandel L, Chartrel N, Knauf C, Raad C, Valet P, Llorens-Cortes C.
    Am J Physiol Endocrinol Metab; 2011 Nov; 301(5):E955-66. PubMed ID: 21846903
    [Abstract] [Full Text] [Related]

  • 9. Leptin regulation of Agrp and Npy mRNA in the rat hypothalamus.
    Korner J, Savontaus E, Chua SC, Leibel RL, Wardlaw SL.
    J Neuroendocrinol; 2001 Nov; 13(11):959-66. PubMed ID: 11737554
    [Abstract] [Full Text] [Related]

  • 10. Effects of subcutaneous leptin injections on hypothalamic gene profiles in lean and ob/ob mice.
    Duan J, Choi YH, Hartzell D, Della-Fera MA, Hamrick M, Baile CA.
    Obesity (Silver Spring); 2007 Nov; 15(11):2624-33. PubMed ID: 18070753
    [Abstract] [Full Text] [Related]

  • 11. Adrenalectomy reverses obese phenotype and restores hypothalamic melanocortin tone in leptin-deficient ob/ob mice.
    Makimura H, Mizuno TM, Roberts J, Silverstein J, Beasley J, Mobbs CV.
    Diabetes; 2000 Nov; 49(11):1917-23. PubMed ID: 11078460
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Hyperphagia and weight gain after gold-thioglucose: relation to hypothalamic neuropeptide Y and proopiomelanocortin.
    Bergen HT, Mizuno TM, Taylor J, Mobbs CV.
    Endocrinology; 1998 Nov; 139(11):4483-8. PubMed ID: 9794456
    [Abstract] [Full Text] [Related]

  • 17. Leptin infusion and obesity in mouse cause alterations in the hypothalamic melanocortin system.
    Gout J, Sarafian D, Tirard J, Blondet A, Vigier M, Rajas F, Mithieux G, Begeot M, Naville D.
    Obesity (Silver Spring); 2008 Aug; 16(8):1763-9. PubMed ID: 18551122
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Chronic blockade of the melanocortin 4 receptor subtype leads to obesity independently of neuropeptide Y action, with no adverse effects on the gonadotropic and somatotropic axes.
    Raposinho PD, Castillo E, d'Alleves V, Broqua P, Pralong FP, Aubert ML.
    Endocrinology; 2000 Dec; 141(12):4419-27. PubMed ID: 11108250
    [Abstract] [Full Text] [Related]

  • 20. Changes in hypothalamic expression levels of galanin-like peptide in rat and mouse models support that it is a leptin-target peptide.
    Kumano S, Matsumoto H, Takatsu Y, Noguchi J, Kitada C, Ohtaki T.
    Endocrinology; 2003 Jun; 144(6):2634-43. PubMed ID: 12746327
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 27.